USA flag logo/image

An Official Website of the United States Government

Novel Molecular Approaches to Discover and Identify Bacterial Virulence Factors

Award Information

Agency:
Department of Defense
Branch:
N/A
Award ID:
Program Year/Program:
2011 / SBIR
Agency Tracking Number:
11SB1-0038
Solicitation Year:
2011
Solicitation Topic Code:
SB111-002
Solicitation Number:
2011.1
Small Business Information
ECKSTEIN DIAGNOSTICS, INC.
4763 Westridge Drive Fort Collins, CO -
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2011
Title: Novel Molecular Approaches to Discover and Identify Bacterial Virulence Factors
Agency: DOD
Contract: W31P4Q-11-C-0215
Award Amount: $100,000.00
 

Abstract:

The occurrence of new emerging infectious disease without efficient treatment opportunities and the increased numbers of multi-resistant primarily bacterial pathogen puts strong pressure on the identification of new drug targets and ultimately the development of new drugs and new types of treatment. There are few target groups that are of particular interest for the development of new drugs and treatment types: (1) surface molecules that play an important role in the host-pathogen interaction and (2) pathogenicity/virulence factors of the bacterial pathogen. Over the last decades new techniques were develop to decipher genomic and proteomic information to identify proteomic factors involved in pathogenicity and virulence. However, none were developed to discover the involvement of lipids in pathogenicity and virulence of bacterial infections mostly due to their specific chemical structure and inability to dissolve in solutions that are non-toxic to eukaryotic cells or are without stimulation of unspecific immune response of immune cells and systems. The purpose of this topic is to identify and validate new techniques to identify easier and faster potential virulence vectors as potential drug targets. In response to this need, Eckstein Diagnostics Inc. proposes the development of a procedure to identify lipids as potential virulence factors.

Principal Investigator:

Gail Berardino-Lang
R&D Director
(970) 222-9127
arthro@frii.com

Business Contact:

Torsten Eckstein
President/CEO
(970) 223-3203
tmeckstein@ecksteindiagnostics.com
Small Business Information at Submission:

Eckstein Diagnostics
4763 Westridge Drive Fort Collins, CO -

EIN/Tax ID: 261704067
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: Yes